Senti Biosciences Inc.

3.10
-0.56 (-15.30%)
At close: Feb 28, 2025, 3:49 PM
3.53
13.87%
Pre-market: Mar 03, 2025, 04:07 AM EST

Senti Biosciences Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 2.56M 4.29M 2.29M 394K 85K
Cost of Revenue 5.24M 3.92M 3.01M 15.96M 14.52M
Gross Profit -2.68M 366K -719K -15.56M -14.44M
Operating Income -92.73M -70.63M -40.45M -24.69M -21.78M
Interest Income 2.86M 1.7M 11K 88K 674K
Pretax Income -83.41M -58.21M -55.32M -19.86M -21.16M
Net Income -92.92M -58.21M -55.32M -19.86M -21.16M
Selling & General & Admin 34.87M 40.85M 21.25M 9.3M 7.34M
Research & Development 32.15M 34.07M 21.96M 15.96M 14.52M
Other Expenses 27.69M 12.42M -470K -172K n/a
Operating Expenses 95.29M 74.92M 42.74M 25.09M 7.39M
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 94.7M 74.92M 42.74M 25.09M 21.92M
Income Tax n/a -12.42M 11K 150K n/a
Shares Outstanding (Basic) 4.44M 2.61M 4.37M 4.37M 13.59M
Shares Outstanding (Diluted) 4.44M 2.61M 4.37M 4.37M 13.59M
EPS (Basic) -16.01 -22.29 -12.67 -4.55 -1.56
EPS (Diluted) -16.01 -22.29 -12.67 -4.55 -1.56
EBITDA -61.34M -70.63M -39.68M -22.71M -21.36M
Depreciation & Amortization 5.43M 3.89M 3.01M 1.99M 427K